MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Avadel Pharmaceuticals plc Cash Conversion Cycle 2011-2026 | AVDL
Annual Cash Conversion Cycle Avadel Pharmaceuticals plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 192 | -1.85 K | - | - | 447 | -2.35 | 75.6 | 5.23 | -59.8 | -185 | 74.9 | 230 | 54 | -42.6 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 447 | -1.85 K | -88.4 |
Quarterly Cash Conversion Cycle Avadel Pharmaceuticals plc
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.9 | 232 | 264 | - | 151 | 4.13 | -184 | - | -7.09 K | -27.6 K | - | - | - | - | - | - | - | - | - | - | - | 32.9 | 27.6 | - | -28.7 | -20.7 | 36.8 | - | 89.2 | 68.3 | 35.4 | - | 2.22 | 2.72 | -32.1 | - | -72.7 | -48 | -29.2 | - | -46 | -115 | -84.8 | - | 15.9 | -83.5 | -129 | - | 23.6 | -8.8 | -95.2 | - | -49 | -90.6 | -139 | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 264 | -27.6 K | -1.03 K |
Cash Conversion Cycle of other stocks in the Drug manufacturers industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aerie Pharmaceuticals
AERI
|
460 | - | - | $ 754 M |  USA |
 |
AcelRx Pharmaceuticals
ACRX
|
-58.9 | - | 7.5 % | $ 6.35 M | USA |
 |
Catalent
CTLT
|
110 | - | - | $ 11.5 B | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-224 | - | 0.86 % | $ 117 M | USA |
 |
DURECT Corporation
DRRX
|
41.4 | - | - | $ 50.1 M | USA |
 |
Canopy Growth Corporation
CGC
|
177 | $ 1.1 | 3.77 % | $ 118 M |  Canada |
 |
Endo International plc
ENDP
|
141 | - | - | $ 28.9 M |  Irlanda |
 |
Agile Therapeutics
AGRX
|
-206 | - | 10.11 % | $ 58.2 M | USA |
 |
Evoke Pharma
EVOK
|
45.7 | - | - | $ 36.6 M | USA |
 |
Alimera Sciences
ALIM
|
-128 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
213 | $ 2.66 | 2.12 % | $ 1.35 B | Canada |
 |
Evolus
EOLS
|
74.8 | $ 5.46 | 32.2 % | $ 352 M | USA |
 |
Jupiter Wellness
JUPW
|
-21.1 | - | - | $ 33.6 M | USA |
 |
China Pharma Holdings
CPHI
|
164 | $ 0.57 | 3.55 % | $ 9.95 M |  China |
 |
Cumberland Pharmaceuticals
CPIX
|
-161 | $ 4.58 | - | $ 64.4 M | USA |
 |
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M | Canada |
 |
Aurora Cannabis
ACB
|
1.45 K | $ 3.65 | 4.89 % | $ 86.3 M | Canada |
 |
Athenex
ATNX
|
137 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
18.3 | $ 39.84 | 3.2 % | $ 1.46 B | USA |
 |
Emergent BioSolutions
EBS
|
181 | $ 8.88 | -0.34 % | $ 455 M | USA |
 |
ProPhase Labs
PRPH
|
96 | - | - | $ 5.07 M | USA |
 |
Assertio Holdings
ASRT
|
327 | $ 11.86 | -0.29 % | $ 842 M | USA |
 |
Radius Health
RDUS
|
-53.5 | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
78.9 | $ 5.63 | -1.66 % | $ 2.05 B | Canada |
 |
Lannett Company
LCI
|
173 | - | 1.15 % | $ 7.11 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
139 | - | -39.89 % | $ 27.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
64.5 | $ 2.89 | 0.7 % | $ 381 M | USA |
 |
OrganiGram Holdings
OGI
|
2.92 K | $ 1.4 | 1.85 % | $ 402 M | Canada |
 |
Rockwell Medical
RMTI
|
45 | $ 0.89 | -1.05 % | $ 20.8 M | USA |
 |
Perrigo Company plc
PRGO
|
137 | $ 11.57 | 1.62 % | $ 1.6 B | USA |
 |
Veru
VERU
|
6.7 | $ 2.56 | 1.39 % | $ 345 M | USA |
 |
Viatris
VTRS
|
155 | $ 14.89 | -0.03 % | $ 17.9 B | USA |
 |
cbdMD
YCBD
|
92 | $ 0.76 | -2.68 % | $ 3.28 M | USA |
 |
TherapeuticsMD
TXMD
|
-723 | $ 2.3 | 3.57 % | $ 24 M | USA |
 |
Pacira BioSciences
PCRX
|
209 | $ 22.11 | 0.05 % | $ 1.02 B | USA |
 |
PetIQ
PETQ
|
53.8 | - | 1.64 % | $ 400 M | USA |
 |
OptiNose
OPTN
|
314 | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
111 | - | -27.8 % | $ 2.56 M | USA |
 |
Recro Pharma
REPH
|
105 | - | -4.76 % | $ 65.3 M | USA |
 |
SCYNEXIS
SCYX
|
106 | $ 0.75 | -0.27 % | $ 35.9 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
150 | $ 2.75 | - | $ 3.41 M | USA |
 |
Tilray
TLRY
|
169 | $ 7.53 | 2.31 % | $ 4.65 B | Canada |